Schedule a Consultation with Dr. Rohan Bhise: Experienced Doctor at KLE Hospital

About Doctor

Dr. Rohan B. Bhise, MBBS, MD, DM, is a highly experienced Medical Oncologist with 14 years of expertise in treating a variety of conditions, including Chronic myeloid leukemia, Acute promyelocytic Leukemia, Esophageal Squamous Cell Carcinoma, Head, and Neck Squamous Cell Carcinoma, Soft Tissue Sarcomas, and Lung cancer. He is fluent in Kannada, English, Hindi, and Marathi. Dr. Bhise is currently practicing at KLE Cancer Hospital in Belagavi, where he has been instrumental in pioneering procedures such as Chemoradiation, Concurrent Weekly Cisplatin, Simultaneous Integrated Boost-IMRT, Imatinibmesylate, Cetuximab and Radiotherapy, and Systemic Therapy. He has published numerous original articles in renowned medical journals, focusing on improving treatment outcomes for various cancers. With a strong dedication to patient care and a track record of successful treatment strategies, Dr. Bhise is a trusted healthcare provider in the field of Medical Oncology.

Past Experiences

KLES Dr. Prabhakar Kore Hospital, Belagavi 2 Years
KLE Cancer Hospital Belagavi 12 Years

Expertise

Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapy
Radiation therapy
Stem cell transplant

Conditions Treated

Chronic myeloid leukemia
Acute promyelocytic Leukemia
Esophageal Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Soft Tissue Sarcomas
Lung cancer

Procedures

Chemoradiation
Concurrent Weekly Cisplatin
Simultaneous Integrated Boost-IMRT
Imatinibmesylate
Cetuximab and Radiotherapy
Systemic Therapy

Memberships

Publications

International ORIGINAL ARTICLE: CLINICAL
Original Article Chronic myeloid leukemia in children and adolescents: results of treatment with imatinibmesylateLeukemia& Lymphoma, December 2012; 53(12): 2430–2433
Original Article Acute promyelocytic Leukemia: Simplifying Treatment in a Resource Poor Setting. Asian Pacific Journal of cancer Care. Volume 6, Issue 4; Acceptance 14/08/2021.
Original Article Definitive Chemoradiation with concurrent weekly cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A simplistic Approach. Asian Pacific Journal of cancer Care. Volume 6, Issue 2; Acceptance 27/04/2021.
Original Article Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma—An Institutional Experience South Asian Journal of Cancer Vol. 11 No. 3/2022
Original Article The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey Clinical and Translational Radiation Oncology 34 (2022) 75–81 Received 27 October 2021; Received in revised form 16 March 2022; Accepted 19 March 2022, Available online 23 March 2022
National:
Psychological Issues and Cancer: Delhi Psychiatry Journal Vol.15 No.1 April 2012
Systemic Therapy in Soft Tissue Sarcomas: Past, Present and Future. Indian J Surgical Oncology (October–December 2011) 2(4):327–331
Systemic Therapy in Head and Neck Cancer: Changing Paradigm Received: 18 May 2012 / Accepted: 18 November 2012: Indian Association of Surgical Oncology 2012
An Unusual Presentation of Primary Rib Non-Hodgkin's Lymphoma Masquerading as Male Breast Cancer Received: 19 May 2012 / Accepted: 31 July 2012 / Published online: 14 August 2012: Indian Association of Surgical Oncology -2012
Lung cancer: A wide clinical spectrum JIACM 2012; 13(2): 162-7

Dr. Rohan B.Bhise